Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.51M |
| 2 |
Akamai
AKAM
|
+$2.28M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$1.3M |
| 4 |
CarMax
KMX
|
+$784K |
| 5 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$347K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nucor
NUE
|
+$2.97M |
| 2 |
Warner Bros
WBD
|
+$2.71M |
| 3 |
Estee Lauder
EL
|
+$1.54M |
| 4 |
DuPont de Nemours
DD
|
+$1.38M |
| 5 |
ASML
ASML
|
+$1.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.54% |
| 2 | Consumer Staples | 20.53% |
| 3 | Technology | 15.72% |
| 4 | Communication Services | 9.26% |
| 5 | Materials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Warner Bros
WBD
$71.6B
| $6.18M | 3.89% |
214,600
-116,127
| -35% | -$2.71M |
|
|
2
ASML
ASML
$677B
| $5.89M | 3.71% |
5,510
-1,258
| -19% | -$1.31M |
|
|
3
Estee Lauder
EL
$36.9B
| $5.74M | 3.61% |
54,803
-15,885
| -22% | -$1.54M |
|
4
CVS Health
CVS
$119B
| $5.69M | 3.58% |
71,685
-10,674
| -13% | -$841K |
|
5
GSK
GSK
$105B
| $5.61M | 3.53% |
114,336
-27,443
| -19% | -$1.28M |
|
6
Boeing
BA
$169B
| $5.52M | 3.47% |
25,427
-3,065
| -11% | -$630K |
|
7
Biogen
BIIB
$32B
| $5.37M | 3.38% |
30,516
-7,838
| -20% | -$1.28M |
|
|
8
DuPont de Nemours
DD
$18.7B
| $5.36M | 3.37% |
44,416
-12,286
| -22% | -$1.38M |
|
9
AB InBev
BUD
$155B
| $5.29M | 3.33% |
82,631
-8,107
| -9% | -$503K |
|
10
International Flavors & Fragrances
IFF
$21.5B
| $5.12M | 3.22% |
76,031
-3,233
| -4% | -$209K |
|
11
Microsoft
MSFT
$3.59T
| $5.12M | 3.22% |
10,585
-885
| -8% | -$443K |
|
|
12
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $4.55M | 2.86% |
+6,676
| New | +$4.51M |
|
13
Pfizer
PFE
$160B
| $4.37M | 2.75% |
175,304
-41,248
| -19% | -$1.04M |
|
14
Nike
NKE
$60.5B
| $4.34M | 2.73% |
68,140
-6,015
| -8% | -$392K |
|
|
15
CarMax
KMX
$8.82B
| $4.29M | 2.7% |
111,088
+19,599
| +21% | +$784K |
|
16
Kraft Heinz
KHC
$30.3B
| $4.29M | 2.7% |
176,807
-34,344
| -16% | -$854K |
|
17
Zimmer Biomet
ZBH
$19.3B
| $4.13M | 2.6% |
45,969
-6,846
| -13% | -$649K |
|
18
Baxter International
BAX
$13.6B
| $4.04M | 2.54% |
211,541
-25,062
| -11% | -$501K |
|
19
Campbell Soup
CPB
$7.14B
| $3.92M | 2.47% |
140,684
-32,350
| -19% | -$973K |
|
20
Brown-Forman Class B
BF.B
$13.1B
| $3.86M | 2.43% |
148,052
-40,202
| -21% | -$1.13M |
|
21
Bristol-Myers Squibb
BMY
$137B
| $2.91M | 1.83% |
53,966
-15,474
| -22% | -$744K |
|
22
TSMC
TSM
$2.17T
| $2.87M | 1.81% |
9,444
-1,731
| -15% | -$508K |
|
23
US Bancorp
USB
$96.7B
| $2.84M | 1.79% |
53,293
-9,000
| -14% | -$443K |
|
|
24
Akamai
AKAM
$15.9B
| $2.79M | 1.76% |
31,999
+27,766
| +656% | +$2.28M |
|
25
Walt Disney
DIS
$186B
| $2.79M | 1.76% |
24,539
-2,913
| -11% | -$321K |
|
Similar funds
Mark Hillman's Q4 2025 Portfolio in Review
As of Q4 2025, Mark Hillman held 56 positions worth $159M, down 7.5% from $172M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mark Hillman withdrew a net $17.5M in Q4 2025, reducing 45 holdings. Its largest reduction was Nucor, cutting an estimated $2.97M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Mark Hillman opened a new position in State Street SPDR S&P 500 ETF Trust worth $4.55M.
- Mark Hillman's largest Q4 2025 buy was State Street SPDR S&P 500 ETF Trust: 6,676 shares worth $4.55M.
- Mark Hillman added most to Akamai in Q4 2025, an estimated $2.28M increase.
- Mark Hillman's biggest Q4 2025 reduction was Nucor, cutting an estimated $2.97M.
- Mark Hillman's ten largest holdings make up 35% of its $159M portfolio in Q4 2025.
- Mark Hillman opened 3 new positions and closed 0 in Q4 2025.
- Mark Hillman's portfolio value fell 7.5% quarter-over-quarter to $159M.
Based on Hillman Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.